Skip to content
healthcare.dev

BORUZU

NDC 70121-2484, Bortezomib, injection, from Amneal Pharmaceuticals LLC.

Product NDC
70121-2484
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
INJECTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212782
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2484 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB3.5 mg/1.4mL

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
70121-2484-1701212484011 VIAL, SINGLE-DOSE in 1 CARTON (70121-2484-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b92628dd-fa09-4c3a-b6a3-66426025807c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70121-2484

Use it

Look up 70121-2484 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2484 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70121-2484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.